Literature DB >> 27083903

Validation of Criteria to Guide Prehospital Naloxone Administration for Drug-Related Altered Mental Status.

Matt S Friedman1, Alex F Manini2.   

Abstract

INTRODUCTION: We aimed to validate previously derived clinical criteria to predict successful prehospital response to naloxone in patients with altered mental status treated by EMS. We hypothesized that prehospital naloxone criteria would have high sensitivity for effective antidote response, but would be underutilized, in patients with drug-related altered mental status (DRAMS).
METHODS: This study was a secondary data analysis of a prospective cohort of acute DRAMS at an urban ED. Naloxone criteria (respiratory rate (RR) <12, miotic pupils, or drug paraphernalia) and mental status, graded by either AVPU (Alert, Verbal, Painful, Unresponsive) or Glasgow Coma Scales, were abstracted from prehospital care reports. Interventions were compared for effective antidote response (EAR), defined as immediate improvement in RR, AVPU, or GCS.
RESULTS: EMS transported 249 DRAMS over 17 months (48 % males, mean age 41.5, ALS 33.7 %). Forty-three (17 %) patients met naloxone criteria, of whom 44.2 % received the antidote. Naloxone criteria significantly predicted EAR (OR 7.0, p < 0.05) with 83 % sensitivity (95 % CI, 55-95 %). Miotic pupils (OR 20.0, p < 0.01) outperformed RR (OR 2.3, p = NS) as the best single criterion with 91 % sensitivity (95 % CI, 62-98 %).
CONCLUSIONS: This study validates prehospital criteria to guide naloxone administration. In addition, prehospital naloxone was underutilized for DRAMS. Further studies should address potential barriers to prehospital naloxone administration.

Entities:  

Keywords:  Naloxone; Overdose; Prehospital

Mesh:

Substances:

Year:  2016        PMID: 27083903      PMCID: PMC4996789          DOI: 10.1007/s13181-016-0549-5

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  18 in total

1.  Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose.

Authors:  Alex F Manini; Robert S Hoffman; Barry Stimmel; David Vlahov
Journal:  Acad Emerg Med       Date:  2015-04-22       Impact factor: 3.451

2.  No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose.

Authors:  David A Wampler; D Kimberley Molina; John McManus; Philip Laws; Craig A Manifold
Journal:  Prehosp Emerg Care       Date:  2011 Jul-Sep       Impact factor: 3.077

3.  Out-of-hospital treatment of opioid overdoses in an urban setting.

Authors:  K A Sporer; J Firestone; S M Isaacs
Journal:  Acad Emerg Med       Date:  1996-07       Impact factor: 3.451

4.  Observer variability in assessing impaired consciousness and coma.

Authors:  G Teasdale; R Knill-Jones; J van der Sande
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

5.  Characteristics of cardiac arrest and resuscitation by age group: an analysis from the Swedish Cardiac Arrest Registry.

Authors:  Johan Herlitz; Leif Svensson; Johan Engdahl; Jan Gelberg; Johan Silfverstolpe; Aase Wisten; Karl-Axel Angquist; Stig Holmberg
Journal:  Am J Emerg Med       Date:  2007-11       Impact factor: 2.469

Review 6.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

7.  Chart reviews in emergency medicine research: Where are the methods?

Authors:  E H Gilbert; S R Lowenstein; J Koziol-McLain; D C Barta; J Steiner
Journal:  Ann Emerg Med       Date:  1996-03       Impact factor: 5.721

8.  Out-of-hospital care of critical drug overdoses involving cardiac arrest.

Authors:  Valentine L Paredes; Thomas D Rea; Mickey S Eisenberg; Leonard A Cobb; Michael K Copass; Anthony Cagle; Thomas G Martin
Journal:  Acad Emerg Med       Date:  2004-01       Impact factor: 3.451

9.  The economic burden of opioid-related poisoning in the United States.

Authors:  Timothy J Inocencio; Norman V Carroll; Edward J Read; David A Holdford
Journal:  Pain Med       Date:  2013-07-10       Impact factor: 3.750

10.  The empiric use of naloxone in patients with altered mental status: a reappraisal.

Authors:  J R Hoffman; D L Schriger; J S Luo
Journal:  Ann Emerg Med       Date:  1991-03       Impact factor: 5.721

View more
  6 in total

1.  Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteers.

Authors:  Arne Kristian Skulberg; Ida Tylleskar; Turid Nilsen; Sissel Skarra; Øyvind Salvesen; Trond Sand; Thorsteinn Loftsson; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2018-03-22       Impact factor: 2.953

2.  Risk factors for severe respiratory depression from prescription opioid overdose.

Authors:  Lindsay M Fox; Robert S Hoffman; David Vlahov; Alex F Manini
Journal:  Addiction       Date:  2017-09-06       Impact factor: 6.526

3.  Identification of Non-Fatal Opioid Overdose Cases Using 9-1-1 Computer Assisted Dispatch and Prehospital Patient Clinical Record Variables.

Authors:  Olufemi Ajumobi; Silvia R Verdugo; Brian Labus; Patrick Reuther; Bradford Lee; Brandon Koch; Peter J Davidson; Karla D Wagner
Journal:  Prehosp Emerg Care       Date:  2021-10-27       Impact factor: 2.686

4.  Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil.

Authors:  Ida Tylleskar; Arne Kristian Skulberg; Sissel Skarra; Turid Nilsen; Ola Dale
Journal:  Eur J Clin Pharmacol       Date:  2018-08-24       Impact factor: 2.953

5.  Poisoning with Drugs of Abuse: Identification and Management.

Authors:  Lekhansh Shukla; Deepak S Ghadigaonkar; Pratima Murthy
Journal:  Indian J Crit Care Med       Date:  2019-12

Review 6.  Altered Mental Status: Current Evidence-based Recommendations for Prehospital Care.

Authors:  Ashley Sanello; Marianne Gausche-Hill; William Mulkerin; Karl A Sporer; John F Brown; Kristi L Koenig; Eric M Rudnick; Angelo A Salvucci; Gregory H Gilbert
Journal:  West J Emerg Med       Date:  2018-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.